Investment analysts at StockNews.com initiated coverage on shares of IRIDEX (NASDAQ:IRIX – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the medical equipment provider’s stock.
IRIDEX Stock Down 3.1 %
IRIX opened at $1.54 on Thursday. The firm has a market cap of $25.03 million, a price-to-earnings ratio of -2.30 and a beta of 0.78. IRIDEX has a 52 week low of $1.45 and a 52 week high of $3.65. The business’s 50 day moving average is $1.82 and its two-hundred day moving average is $2.20.
IRIDEX (NASDAQ:IRIX – Get Free Report) last released its earnings results on Thursday, August 8th. The medical equipment provider reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.04). The company had revenue of $12.63 million during the quarter, compared to analyst estimates of $12.80 million. IRIDEX had a negative net margin of 21.84% and a negative return on equity of 134.37%. During the same period in the previous year, the firm posted ($0.17) EPS. Equities analysts expect that IRIDEX will post -0.52 EPS for the current fiscal year.
Hedge Funds Weigh In On IRIDEX
IRIDEX Company Profile
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Recommended Stories
- Five stocks we like better than IRIDEX
- What is a Dividend King?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Use the MarketBeat Dividend Calculator
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for IRIDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX and related companies with MarketBeat.com's FREE daily email newsletter.